Personalised Immunotherapy in Sepsis:
a precision medicine approach

Key figures

Duration
4 Years
Funding
10 Million €
14 Partners
9 Countries

Countries involved

The Netherlands
Austria
France
Germany
Greece
Israel
Romania
Switzerland
United Kingdom